Related Experiment Video

Updated: Jan 16, 2026

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
12:23

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

20.9K

[Osteoarthritis and cellular therapeutics]

Margaux Gritten1, Jean-François Kaux1

  • 1Service de Médecine physique, CHU Liège, Belgique.

Revue Medicale De Liege
|January 15, 2026
PubMed

Insights

Osteoarthritis causes cartilage damage, pain, and functional loss. Mesenchymal stem cells (MSCs) and their exosomes show promise for treating this degenerative joint disorder, though further research is needed.

Area of Science:

  • Orthopedics and Regenerative Medicine

Background:

  • Osteoarthritis (OA) is a degenerative joint disease characterized by progressive cartilage breakdown, leading to pain and disability.
  • OA presents heterogeneously with diverse phenotypes and molecular signatures.
  • Key risk factors include aging, female sex, obesity, and joint injury.

Purpose of the Study:

  • To explore emerging therapeutic strategies for osteoarthritis.
  • To highlight the potential of mesenchymal stem cells (MSCs) and MSC-derived exosomes in OA treatment.

Main Methods:

  • Review of current literature on osteoarthritis pathogenesis and treatment.
  • Analysis of the regenerative and immunomodulatory properties of MSCs.
  • Evaluation of MSC-derived exosomes as a cell-free therapeutic approach.

Main Results:

  • Mesenchymal stem cells (MSCs) derived from various tissues demonstrate regenerative potential for osteoarthritis.
  • MSC-derived exosomes carry bioactive factors with therapeutic implications for OA.
  • Further clinical validation is required for the application of MSC-derived exosomes.

Conclusions:

  • Mesenchymal stem cells (MSCs) represent a promising therapeutic avenue for osteoarthritis.
  • MSC-derived exosomes offer innovative potential but require further clinical investigation.
  • Addressing the heterogeneity of OA phenotypes is crucial for targeted therapeutic development.
Keywords:
Cellular therapyExosomeMesenchymal stem cellOsteoarthritis

More Related Videos

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles05:50

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

1.8K
Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

4.4K

Related Concept Videos

Cell-surface Signaling01:21

Cell-surface Signaling

Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
53.8K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
12.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
What is Cell Signaling?02:03

What is Cell Signaling?

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
129.7K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
83.5K